[Influence of L-cysteine on thiram (TMTD)-induced teratogenesis in NMRI-mice].
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D000015:Abnormalities, Multiple / Q000139:chemically induced*; D000284:Administration, Oral; D000818:Animals; D000891:Anti-Infective Agents, Local / Q000009:adverse effects*; D003545:Cysteine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D005260:Female; D005333:Fetus / Q000187:drug effects; D005865:Gestational Age; D007274:Injections, Intraperitoneal; D051379:Mice; D008815:Mice, Inbred Strains; D009821:Oils / Q000494:pharmacology; D011247:Pregnancy; D013859:Thiocarbamates / Q000009:adverse effects*; D013893:Thiram / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000633:toxicity
D000891:Anti-Infective Agents, Local; D009821:Oils; D013859:Thiocarbamates; D013893:Thiram; D003545:Cysteine
Uber den Einfluss von L-Cystein auf die Teratogenese durch Thiram (TMTD) bei NMRI-Mäusen.